Acumen Pharmaceuticals



Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Eric Siemers
Chief Medical Officer
Russell Barton
Chief Operating Officer
Kent Iverson
CMC Leader
Robert A Dean
IND Team Leader, Director of Clinical Operations
Jasna Jerecic
Director Analytical Methods
Janice Hitchcock
Head of Regulatory Affairs
Kathlene Powell
Head of Quality Systems
Jerry Moore
Non Clinical Development Leader

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.